Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 2003, p. 3130-3137, Vol. 47, No. 10
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.10.3130-3137.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Rapid Direct Method for Monitoring Antibiotics in a Mouse Model of Bacterial Biofilm Infection
Jagath L. Kadurugamuwa,* Lin V. Sin, Jun Yu, Kevin P. Francis, Richard Kimura, Tony Purchio, and Pamela R. Contag
Xenogen Corporation, Alameda, California 94501
Received 20 February 2003/
Returned for modification 6 June 2003/
Accepted 30 June 2003
We have developed a rapid, continuous method for monitoring the effectiveness of several antibacterial agents in real time, noninvasively, by using a recently described mouse model of chronic biofilm infection (J. L. Kadurugamuwa et al., Infect. Immun. 71:882-890, 2003), which relies on biophotonic imaging of bioluminescent bacteria. To facilitate real-time monitoring of infection, we used a Staphylococcus aureus isolate that was made bioluminescent by inserting a modified lux operon into the bacterial chromosome. This bioluminescent reporter bacterium was used to study the antimicrobial effects of several antibiotics belonging to different molecular families. Treatment with rifampin, tobramycin, and ciprofloxacin was started 7 days after subcutaneous implantation of catheters precolonized with 104 CFU of S. aureus. Three different doses of antibiotics were administered twice a day for 4 consecutive days. The number of metabolically active bacteria in untreated mice and the tobramycin- and ciprofloxacin-treated groups remained relatively unchanged over the 4-week observation period, indicating poor efficacies for tobramycin and ciprofloxacin. A rapid dose-dependent decline in metabolic activity in rifampin-treated groups was observed, with almost a 90% reduction after two doses and nearly undetectable levels after three doses. The disappearance of light emission correlated with colony counts. After the final treatment, cell numbers rebounded as a function of concentration in a time-dependent manner. The staphylococci isolated from the catheters of mice treated with rifampin were uniformly resistant to rifampin but retained their in vitro susceptibilities to tobramycin and ciprofloxacin. Since the metabolic activities of viable cells and a postantibiotic effect could be detected directly on the support matrix nondestructively and noninvasively, the methodology is specifically appealing for investigating the effects of antibiotics on biofilms in vivo. Moreover, our study points to the possible use of biophotonic imaging for the detection of the development of resistance to therapeutic agents during treatment of chronic infections in vivo.
* Corresponding author. Mailing address: Xenogen Corporation, 860 Atlantic Ave., Alameda, CA 94501. Phone: (510) 291-6246. Fax: (510) 291-6196. E-mail: Jagath.Kadurugamuwa{at}Xenogen.com.
Antimicrobial Agents and Chemotherapy, October 2003, p. 3130-3137, Vol. 47, No. 10
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.10.3130-3137.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Robertson, G. T., Bonventre, E. J., Doyle, T. B., Du, Q., Duncan, L., Morris, T. W., Roche, E. D., Yan, D., Lynch, A. S.
(2008). In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus. Antimicrob. Agents Chemother.
52: 2313-2323
[Abstract]
[Full Text]
-
Kang, J. H., Chung, J.-K.
(2008). Molecular-Genetic Imaging Based on Reporter Gene Expression. JNM
49: 164S-179S
[Abstract]
[Full Text]
-
Lane, M. C., Alteri, C. J., Smith, S. N., Mobley, H. L. T.
(2007). Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl. Acad. Sci. USA
104: 16669-16674
[Abstract]
[Full Text]
-
Thorn, R. M. S., Nelson, S. M., Greenman, J.
(2007). Use of a Bioluminescent Pseudomonas aeruginosa Strain within an In Vitro Microbiological System, as a Model of Wound Infection, To Assess the Antimicrobial Efficacy of Wound Dressings by Monitoring Light Production. Antimicrob. Agents Chemother.
51: 3217-3224
[Abstract]
[Full Text]
-
Mortin, L. I., Li, T., Van Praagh, A. D. G., Zhang, S., Zhang, X.-X., Alder, J. D.
(2007). Rapid Bactericidal Activity of Daptomycin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Peritonitis in Mice as Measured with Bioluminescent Bacteria. Antimicrob. Agents Chemother.
51: 1787-1794
[Abstract]
[Full Text]
-
Kadurugamuwa, J. L., Modi, K., Coquoz, O., Rice, B., Smith, S., Contag, P. R., Purchio, T.
(2005). Reduction of Astrogliosis by Early Treatment of Pneumococcal Meningitis Measured by Simultaneous Imaging, In Vivo, of the Pathogen and Host Response. Infect. Immun.
73: 7836-7843
[Abstract]
[Full Text]
-
Kadurugamuwa, J. L., Modi, K., Yu, J., Francis, K. P., Purchio, T., Contag, P. R.
(2005). Noninvasive Biophotonic Imaging for Monitoring of Catheter-Associated Urinary Tract Infections and Therapy in Mice. Infect. Immun.
73: 3878-3887
[Abstract]
[Full Text]
-
Yu, J., Wu, J., Francis, K. P., Purchio, T. F., Kadurugamuwa, J. L.
(2005). Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model. J Antimicrob Chemother
55: 528-534
[Abstract]
[Full Text]
-
Xiong, Y. Q., Willard, J., Kadurugamuwa, J. L., Yu, J., Francis, K. P., Bayer, A. S.
(2005). Real-Time In Vivo Bioluminescent Imaging for Evaluating the Efficacy of Antibiotics in a Rat Staphylococcus aureus Endocarditis Model. Antimicrob. Agents Chemother.
49: 380-387
[Abstract]
[Full Text]
-
Jawhara, S., Mordon, S.
(2004). In Vivo Imaging of Bioluminescent Escherichia coli in a Cutaneous Wound Infection Model for Evaluation of an Antibiotic Therapy. Antimicrob. Agents Chemother.
48: 3436-3441
[Abstract]
[Full Text]
-
Kadurugamuwa, J. L., Sin, L. V., Yu, J., Francis, K. P., Purchio, T. F., Contag, P. R.
(2004). Noninvasive Optical Imaging Method To Evaluate Postantibiotic Effects on Biofilm Infection In Vivo. Antimicrob. Agents Chemother.
48: 2283-2287
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.